SCHEMBL204164

SCHEMBL204164

O=C(O)c1cc(Cl)c2c(c1Cl)C(=O)OC21c2cc(Cl)c(O)c(Cl)c2Oc2c1cc(Cl)c(O)c2Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
THRB P10828 3/20 0.48
RECQL P46063 3/20 0.48
TDP1 Q9NUW8 3/20 0.48
HPGD P15428 3/20 0.48
HSD17B10 Q99714 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
BRCA1 P38398 2/20 0.48
BLM P54132 2/20 0.48
TSHR P16473 2/20 0.48
CYP3A4 P08684 1/20 0.48
MAPK1 P28482 1/20 0.48
CASP1 P29466 1/20 0.48
HIF1A Q16665 1/20 0.48
GLB1 P16278 1/20 0.48
CTRC Q99895 1/20 0.48
SMAD3 P84022 1/20 0.46
AKR1C2 P52895 4/20 0.35
AKR1C1 Q04828 4/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL202598 0.91 ALDH1A1 (0.48) ALDH1A1THRBRECQLTDP1HPGD
SCHEMBL8359568 0.87 TDP1 (0.43) ALDH1A1THRBRECQLTDP1HPGD
SCHEMBL5094500 0.87 THRB (0.41) ALDH1A1THRBRECQLTDP1HPGD
SCHEMBL18171688 0.85 ALDH1A1 (0.44) ALDH1A1THRBRECQLTDP1HPGD
SCHEMBL3472516 0.85 THRB (0.44) ALDH1A1THRBRECQLTDP1HPGD
SCHEMBL347626 0.82 THRB (0.50) ALDH1A1THRBRECQLTDP1HPGD
SCHEMBL1022908 0.81 SMAD3 (0.40) ALDH1A1THRBRECQLTDP1HPGD
SCHEMBL7589676 0.79 SMAD3 (0.37) ALDH1A1THRBRECQLTDP1HPGD
SCHEMBL229962 0.78 ALDH1A1 (0.43) ALDH1A1THRBRECQLTDP1HPGD
SCHEMBL5665945 0.78 ALDH1A1 (0.58) ALDH1A1THRBRECQLTDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116589475-B Preparation method of 2',4',5',7' -tetrachloro-5 (6) -carboxyl-4, 7-dichloro fluorescein 北京欧凯纳斯生化科技有限公司 2023-09-29 CN claimed
CN-116589475-A Preparation method of 2',4',5',7' -tetrachloro-5 (6) -carboxyl-4, 7-dichloro fluorescein 北京欧凯纳斯生化科技有限公司 2023-08-15 CN claimed
EP-2371927-B1 Fluorescent dye compounds, conjugates and uses thereof LIFE TECHNOLOGIES CORP (US) 2020-03-11 EP claimed
US-9110075-B2 Compositions for analyzing proteins MONOGRAM BIOSCIENCES, INC. (US) 2015-08-18 US claimed
US-8729267-B2 Fluorescent dye compounds, conjugates and uses thereof APPLIED BIOSYSTEMS, LLC (US) 2014-05-20 US claimed
US-20130122506-A1 NUCLEIC ACID BASE ANALOGS WITH QUENCHING AND FLUORESCENT ACTIVITIES AND APPLICATIONS THEREOF TAGCYX BIOTECHNOLOGIES C/O RIKEN (JP) 2013-05-16 US claimed
EP-2562255-A1 NUCLEIC ACID BASE ANALOG WITH QUENCHING CHARACTERISTICS AND FLUORESCENCE AND APPLICATION THEREOF Riken (JP) 2013-02-27 EP claimed
US-8212014-B2 Artificial base pairs and uses thereof RIKEN (JP) 2012-07-03 US claimed
US-20110250699-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof Life Technologies Corporation (US) 2011-10-13 US claimed
EP-2371927-A1 Fluorescent dye compounds, conjugates and uses thereof Life Technologies Corporation (US) 2011-10-05 EP claimed
US-20090275017-A1 Novel Nucleoside or Nucleotide Derivative and Use Thereof RIKEN (JP) 2009-11-05 US claimed
US-20090093062-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof APPLERA CORPORATION (US) 2009-04-09 US claimed
EP-1921141-A1 NOVEL ARTIFICIAL BASE PAIR AND USE THEREOF Riken (JP) 2008-05-14 EP claimed
EP-1816130-A1 NOVEL NUCLEOSIDE OR NUCLEOTIDE DERIVATIVE AND USE THEREOF Riken (JP) 2007-08-08 EP claimed
US-20060063734-A1 4,7-dichlorofluorescein dyes as molecular probes APPLERA CORPORATION (US) 2006-03-23 US claimed
US-20050084870-A1 4,7-dichlorofluorescein dyes as molecular probes APPLERA CORPORATION (US) 2005-04-21 US claimed
EP-0777749-B1 COUPLED AMPLIFICATION AND LIGATION METHOD PE CORP NY (US) 2002-10-30 EP claimed
US-20020081616-A1 4,7-dichlorofluorescein dyes as molecular probes THE PERKIN-ELMER CORPORATION 2002-06-27 US claimed
US-6130073-A DETECTING A TARGET NUCLEOTIDE SEQUENCES IN A SAMPLE; AMPLIFYING TARGET NUCLEOTIDE SEQUENCES BY PRIMER EXTENSION, LIGATING OLIGONUCLEOTIDE PROBES AND DETECTING LIGATION PRODUCTS PERKIN-ELMER CORP., APPLIED BIOSYSTEMS DIVISION (US) 2000-10-10 US claimed
US-5912148-A DETECTION OF POLYNUCLEOTIDE IN SAMPLE BY POLYMERASE CHAIN REACTION AND LIGATION OF OLIGONUCLEOTIDE PROBES WHICH HYBRIDIZE TO AMPLIFICATION PRODUCT, DETECTION OF LIGATION PRODUCT IN ONE REACTION VESSEL PERKIN-ELMER CORPORATION APPLIED BIOSYSTEMS (US) 1999-06-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275017-A1 Novel Nucleoside or Nucleotide Derivative and Use Thereof DUT, NT5C3B, NT5C ALDH1A1 2280/4885THRB 1826/4885RECQL 194/4885
US-20060063734-A1 4,7-dichlorofluorescein dyes as molecular probes SPAG5, SPG11, SPIN4 ALDH1A1 795/4885THRB 4221/4885RECQL 193/4885
US-20050084870-A1 4,7-dichlorofluorescein dyes as molecular probes DCLRE1B, DCTD, DDB1 ALDH1A1 405/4885THRB 3306/4885RECQL 226/4885
US-20020081616-A1 4,7-dichlorofluorescein dyes as molecular probes SPAG5, SPG11, SPIN4 ALDH1A1 658/4885THRB 4266/4885RECQL 202/4885
US-20090093062-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof GFPT1, SLC46A1, SLC7A5 ALDH1A1 146/4885THRB 4151/4885RECQL 1662/4885
US-20110250699-A1 Fluorescent Dye Compounds, Conjugates and Uses Thereof GFPT1, SLC46A1, SLC7A5 ALDH1A1 146/4885THRB 4151/4885RECQL 1662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.